Inventor · disambiguated record
Dave Nichols
Also filed as: NICHOLS DAVE
11 granted patents·5 pending applications·21 citations·filing 2013–2024
86Inventor score
Top patents by PatentIndex Score
16 records- 0191US11530393B2Compositions comprising iduronate-2-sulfataseSHIRE HUMAN GENETIC THERAPIES·Filed 2020·Granted Dec 20, 2022·2 cites·19 claims
- 0289US9051556B2Purification of iduronate-2-sulfataseSHIRE HUMAN GENETIC THERAPIES·Filed 2013·Granted Jun 9, 2015·13 cites·17 claims
- 0388US12359178B2Methods and compositions for treatment of hunter syndrome comprising iduronate-2-sulfataseTAKEDA PHARMACEUTICALS CO·Filed 2024·Granted Jul 15, 2025·0 cites·13 claims
- 0485US2025114449A1Stable anti-osmr antibody formulationKINIKSA PHARMACEUTICALS LTD·Filed 2024·Application pending·0 cites
- 0584US9492511B2Methods and compositions for treatment of hunter syndromeSHIRE HUMAN GENETIC THERAPIES·Filed 2015·Granted Nov 15, 2016·4 cites·20 claims
- 0682US12319940B2Methods for purification of arylsulfatase ATAKEDA PHARMACEUTICALS CO·Filed 2023·Granted Jun 3, 2025·0 cites·20 claims
- 0781US2024043817A1Compositions comprising iduronate-2-sulfataseTAKEDA PHARMACEUTICALS CO·Filed 2022·Application pending·0 cites
- 0880US10344270B2Methods and compositions for treatment of Hunter syndromeSHIRE HUMAN GENETIC THERAPIES·Filed 2016·Granted Jul 9, 2019·2 cites·20 claims
- 0974US11141479B2Stable anti-OSMR antibody formulationKINIKSA PHARMACEUTICALS LTD·Filed 2019·Granted Oct 12, 2021·0 cites·19 claims
- 1073US11884945B2Methods for purification of arylsulfatase ATAKEDA PHARMACEUTICALS CO·Filed 2022·Granted Jan 30, 2024·0 cites·16 claims
- 1173US2022062414A1Stable Anti-OSMR Antibody FormulationKINIKSA PHARMACEUTICALS LTD·Filed 2021·Application pending·0 cites
- 1268US10493149B2Stable anti-OSMR antibody formulationKINIKSA PHARMACEUTICALS LTD·Filed 2018·Granted Dec 3, 2019·0 cites·19 claims
- 1367US10391170B2Stable anti-OSMR antibody formulationKINIKSA PHARMACEUTICALS LTD·Filed 2018·Granted Aug 27, 2019·0 cites·16 claims
- 1466US2019359958A1Methods and compositions for treatment of hunter syndromeSHIRE HUMAN GENETIC THERAPIES·Filed 2019·Application pending·0 cites
- 1553US11407984B2Methods for purification of arysulfatase ATAKEDA PHARMACEUTICALS CO·Filed 2014·Granted Aug 9, 2022·0 cites·28 claims
- 1651US2022281914A1Protein compositions and methods for producing and using the sameKINIKSA PHARMACEUTICALS LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Dave Nichols files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →